Employer record no. 18607
Nexus Pharmaceuticals Inc.
US DOL LCA disclosure data, FY2020 to FY2025
Total LCA filings
17
Certified
16
Denied
0
FY2025 filings
3
Filings by fiscal year
Peer rank
#1,642 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 1 | 1 | 0 | $69,000 | $63,357 |
| FY2021 | 5 | 5 | 0 | $91,577 | $80,442 |
| FY2022 | 2 | 2 | 0 | $95,000 | $87,714 |
| FY2023 | 3 | 2 | 0 | $116,267 | $88,025 |
| FY2024 | 3 | 3 | 0 | $97,588 | $83,935 |
| FY2025 | 3 | 3 | 0 | $115,724 | $105,221 |
What they file for
- formulation scientist ii$88,4214
- analytical scientist ii$97,5002
- analytical scientist iii$111,6282
- lead scientist, formulation development$126,0002
- technical transfer associate$71,4422
- director, analytical research & development$164,8001
- formulation scientist i$90,0001
- formulation scientist iii$105,0001
Where
- lincolnshire, il17
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Nexus Pharmaceuticals Inc. and any other employer they watch.
Certification rate 94.1%How these numbers are computed